Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond annotations (readOnly, openWorld, idempotent), the description discloses rich behavioral detail: the tool cascades through multiple lookup endpoints, degrades gracefully when GLEIF/OpenFIGI are unavailable (EDGAR identifiers still return), asserts nothing on ambiguous matches and returns `figi_candidates` to pick from, lists unresolved identifiers explicitly, and labels every identifier with its source. It also explains that ISINs resolve to the legal entity via GLEIF, covering non-US issuers. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but every sentence carries useful information. It is front-loaded with the core directive ('Use FIRST...') and example queries, then systematically details supported types, source integrations, edge cases, and graceful degradation. The structure (paragraph breaks for types and behaviors) keeps it scannable. No fluff — each clause clarifies a decision the agent must make.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with only 2 parameters and no output schema, the description covers every necessary context: what identifiers are returned (CIK, ticker, LEI, FIGI, RxCUI), how sources are labelled, what happens on ambiguity, what happens on upstream failure, and that it replaces 2-3 manual lookups. There is no missing piece an agent would need to call this tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already describes both parameters (type enum and value string), but the description goes much further. It provides concrete examples for value (ticker, CIK, name; brand/generic drug), explains the exact input format for bonds (issuer name only, not the full noun phrase), and warns about trailing security-class words causing no match. This adds semantic clarity far beyond the schema's generic descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete example queries that identify the exact resource (canonical/official identifiers) and the action (resolve). It explicitly states 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input' and 'Use FIRST whenever you have a name but need an ID.' This distinguishes it from siblings like entity_profile and compare_entities, which consume IDs, making the purpose unmistakable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives a clear directive: 'Use FIRST whenever you have a name but need an ID.' It also specifies when to use which entity type ('company' vs 'drug') and provides input-format guidance (ticker/CIK/name vs brand/generic). It implies that if you already have the ID, you don't need this tool, and it names alternatives indirectly by saying other tools require these IDs. The when-to-use is explicit and actionable.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation4/5

Most tools have distinct purposes, with clear descriptions differentiating similar ones like ask_pipeworx and ask_pipeworx_grounded. A few overlaps exist (multiple Polymarket analysis tools), but descriptions sufficiently resolve ambiguity.

Naming Consistency2/5

Tool naming is inconsistent, mixing descriptive phrases (entity_profile, polymarket_edges) with verb-object patterns (generate_llms_txt, search). No strong convention is followed, and the 'polymarket_' prefix is applied to some betting tools but not others.

Tool Count3/5

32 tools is high but not extreme. However, the scope is too broad for a single server, covering data queries, betting, memory, NYPL, and more, making the set feel bloated and unfocused.

Completeness2/5

The domain is unclear due to mixed tools, but within the NYPL subset there are clear gaps (only search and item, no CRUD). For the other domains, coverage is uneven and lacks clear lifecycle completeness.